Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-NADOLOL 160 MG

NADOLOL : 160 MG · DIN 00782475 · APOTEX INC

Health Canada status: MARKETED

What is APO-NADOLOL?

APO-NADOLOL 160 MG contains NADOLOL : 160 MG. It is listed in the Health Canada Drug Product Database under DIN 00782475, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Feb-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is APO-NADOLOL used for?

APO-NADOLOL (nadolol) is indicated for prophylaxis of angina pectoris. APO-NADOLOL is indicated in patients with mild or moderate hypertension. APO-NADOLOL is usually used in combination with other drugs, particularly a thiazide diuretic. However, it may be tried alone as an initial agent in those patients in whom, in the judgment of the physician, treatment should be started with a beta-blocker rather than a diuretic.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN00782475
Brand nameAPO-NADOLOL
Generic / active ingredientNADOLOL : 160 MG
ManufacturerAPOTEX INC
Strength160 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeC07AA12 NADOLOL
AHFS class24:24.00
BiosimilarNo
Health Canada statusMARKETED
Status date26-Feb-2021
Original market date1988-12-31 00:00:00

How is it stored and handled?

Store tightly closed, at room temperature.

How is it supplied?

40 mg tablets: Available in bottles of 100, 500 and 1000 tablets. 80 mg tablets: Available in bottles of 100, 500 and 1000 tablets. 160 mg tablets: Available in bottles of 100, 500 and 1000 tablets.

What can be used instead?

Other Canadian products sharing ATC code C07AA12 NADOLOL. 5 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-NADOLOL40 MGTABLETAPOTEX INCMARKETEDDIN 00782505
APO-NADOLOL80 MGTabletAPOTEX INCMARKETEDDIN 00782467
MINT-NADOLOL40 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02496380
MINT-NADOLOL80 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02496399
CORGARD TAB 160MG160 MGTABLETBRISTOL-MYERS SQUIBB CANADACANCELLED POST MARKETDIN 00523372
CORGARD TAB 40MG40 MGTABLETBRISTOL-MYERS SQUIBB CANADACANCELLED POST MARKETDIN 00607126
CORGARD TAB 80MG80 MGTABLETBRISTOL-MYERS SQUIBB CANADACANCELLED POST MARKETDIN 00463256
NADOLOL-160 TAB 160MG160 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00818720
NADOLOL-40 TAB 40MG40 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00828815
NADOLOL-80 TAB 80MG80 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00818704

Who else supplies NADOLOL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. NADOLOL appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for APO-NADOLOL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 00782475. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.